ELAVL1 and neoplasm: The size and weight of the tumour xenografts derived from HuR KO1 cells overexpressing BCAT1 were significantly increased compared with those of tumour xenografts derived from HuR KO1 cells without BCAT1 at three weeks (Fig. 6F).